Sun Longhao, Zhang Xuebin, Song Qianqian, Liu Liang, Forbes Elizabeth, Tian Weijun, Zhang Zhixiang, Kang Ya'an, Wang Huamin, Fleming Jason B, Pasche Boris C, Zhang Wei
Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Medical Center, Winston-Salem, NC, 27157, USA; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Department of Pathology, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Cancer Lett. 2021 Mar 1;500:132-146. doi: 10.1016/j.canlet.2020.12.008. Epub 2020 Dec 10.
Tumor-associated macrophages (TAMs) represent the M2-like phenotype with potent immunosuppressive activity, and play a pro-tumor role in pancreatic ductal adenocarcinoma (PDAC) biology. In this study, we investigated the role of the insulin-like growth factor binding protein 2 (IGFBP2) as a determinant of TAM polarity. Clinical data revealed that the levels of IGFBP2 correlated with M2 TAMs accumulation and disease progression in human PDAC. In vivo mouse model experiments showed that IGFBP2 promoted an immunosuppressive microenvironment and tumor growth in a macrophage dependent manner. Bioinformatics analysis of PDAC transcriptomes revealed a significant association between IGFBP2 expression and M2 macrophage polarization and signal transducer and activator of transcription 3 (STAT3) activation. Mechanistic investigations demonstrated that IGFBP2 augmented the expression and secretion of IL-10 through STAT3 activation in PDAC cells, which induced TAM polarization toward an M2 phenotype. IGFBP2-polarized M2 macrophages significantly increased Tregs infiltration and impaired antitumor T-cell immunity in a mouse model. Thus, our investigations have illuminated the IGFBP2 signaling pathway that contributes to the macrophage-based immunosuppressive microenvironment in PDAC, suggesting that blocking the IGFBP2 axis constitutes a potential treatment strategy to reset TAM polarization toward an antitumor state in PDAC.
肿瘤相关巨噬细胞(TAM)呈现出具有强大免疫抑制活性的M2样表型,并在胰腺导管腺癌(PDAC)生物学过程中发挥促肿瘤作用。在本研究中,我们调查了胰岛素样生长因子结合蛋白2(IGFBP2)作为TAM极化决定因素的作用。临床数据显示,IGFBP2水平与人类PDAC中M2 TAM的积累及疾病进展相关。体内小鼠模型实验表明,IGFBP2以巨噬细胞依赖的方式促进免疫抑制微环境和肿瘤生长。对PDAC转录组的生物信息学分析揭示了IGFBP2表达与M2巨噬细胞极化以及信号转导和转录激活因子3(STAT3)激活之间存在显著关联。机制研究表明,IGFBP2通过激活PDAC细胞中的STAT3增强IL-10的表达和分泌,从而诱导TAM向M2表型极化。在小鼠模型中,IGFBP2极化的M2巨噬细胞显著增加调节性T细胞浸润并损害抗肿瘤T细胞免疫。因此,我们的研究阐明了IGFBP2信号通路在PDAC中促成基于巨噬细胞的免疫抑制微环境,这表明阻断IGFBP2轴构成了一种潜在的治疗策略,可使PDAC中的TAM极化恢复到抗肿瘤状态。